{
    "title": "US Patent Office won't review two Novo Nordisk patents for Wegovy, Ozempic",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12586177/US-Patent-Office-wont-review-two-Novo-Nordisk-patents-Wegovy-Ozempic.html",
    "date": "2023-10-02",
    "keywords": [
        "wegovy",
        "viatris",
        "ozempic",
        "mylan",
        "market",
        "blake",
        "brittain",
        "nordisk",
        "ingredient",
        "weightloss",
        "patent",
        "company",
        "reporting",
        "washington",
        "office",
        "tribunal",
        "monday",
        "drugmaker",
        "blockbuster",
        "trial",
        "board",
        "validity",
        "medication",
        "liraglutide",
        "method",
        "treatment",
        "decision",
        "spokesperson",
        "property",
        "request",
        "comment",
        "novos",
        "class",
        "obesity",
        "end",
        "decade",
        "record",
        "type",
        "drug",
        "semaglutide",
        "september",
        "novo",
        "west",
        "court",
        "part",
        "litigation",
        "wingrove",
        "york",
        "editing",
        "bario"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}